Author(s): Ribeiro, Daniela R. ; Sá, Ana Cravo ; Martins, Leonor Santos ; Carolino, Elisabete ; Borrego, Margarida
Date: 2025
Persistent ID: http://hdl.handle.net/10400.22/31109
Origin: Repositório Científico do Instituto Politécnico do Porto
Subject(s): Fertility preservation; Ovarian transposition
Advances in oncology have led to increasingly earlier diagnosis and better survival rates (1). Combined with the current trend towards postponing parenthood, there will be more and more cancer survivors of childbearing age (2). The impact of pelvic radiotherapy on patients' fertility is making oncofertility an emerging clinical area. It is therefore essential that patients have the opportunity to discuss fertility preservation before treatment (3). This study aims (i) to assess whether the doses to the gonads of the 70 patients met the tolerance doses used in radiotherapy planning; (ii) to compare the 3DCRT with the VMAT techniques; (iii) to verify whether ovarian transposition reduces the dose to the ovaries.
